Survivors Journey+: an online family program for teen and young adult brain tumor survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot randomized controlled trial will enroll pediatric brain tumor survivors ages 15–25 who live with a parent or guardian and randomize family dyads to either the Survivors Journey+ (SJ+) online program with weekly coaching or an internet resource comparison (IRC). The SJ+ program is a developmentally tailored, family-centered digital intervention that teaches social problem-solving, emotion-regulation, and metacognitive skills for survivors while offering caregiver strategies to reduce depression and family impact. Outcomes include feasibility and acceptability benchmarks (enrollment, retention, satisfaction) and measures of survivor and caregiver wellbeing collected at baseline and about three months post-baseline. The protocol also includes refining usability and accessibility based on participant feedback.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* a diagnosis of a pediatric intracranial tumor
* tumor-directed treatment completed \> 12 months ago (treatment included: surgery, radiation, or chemotherapy)
* lives with parent/guardian(s)
* language: English must be the primary spoken language in the home

Exclusion Criteria:

* history of tuberous sclerosis or neurofibromatosis
* treatment \< 12 months ago and/or treatment did not include surgery, radiation, or chemotherapy
* history of psychiatric hospitalization
* resides outside of the family home
* history of autism, reactive attachment disorder, psychosis, or other psychiatric diagnoses/conditions associated with significant risk of harm to self or others per caregiver
* English is not the primary language spoken in the home

Where it's running

• Cincinnati Children's Hospital Medical Center
  Cincinnati, Ohio, United States Recruiting
• Nationwide Children's Hospital
  Columbus, Ohio, United States Recruiting

Study contacts

• Principal investigator: Shari L Wade, PhD — Children's Hospital Medical Center, Cincinnati
• Study coordinator: Shari L Wade, PhD
• Email: shari.wade@cchmc.org
• Phone: 513-636-3370

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• GPC2-targeted CAR T cell therapy for relapsed or refractory medulloblastoma in children and young adults

  This trial will test whether autologous GPC2-targeted CAR T cells delivered into the brain ventricle are safe and active for children and young adults with relapsed or refractory medulloblastoma or similar CNS embryonal tumors.

  Recruiting Phase 1 Stanford University · Palo Alto, California · NCT07087002

• Evaluating a Neurologic Assessment Scale for Pediatric Brain and Spine Tumors

  This study is testing a new neurologic exam scale for kids with brain and spine tumors to see how consistently different doctors can use it to check their progress, including doing some assessments through telemedicine.

  Recruiting University of Wisconsin, Madison · Madison, Wisconsin · NCT06981156

• Evaluating magnetoencephalography for pediatric brain tumors

  This study is testing if a special brain imaging technique called magnetoencephalography can help doctors find brain tumors in kids more accurately than regular scans like CT and MRI.

  Recruiting Guangzhou Women and Children's Medical Center · Guangzhou, Guangdong · NCT06943742

• High-Intensity Interval Exercise for Young Adult Survivors of Pediatric Brain Tumors

  This study is testing whether a 16-week online high-intensity exercise program can improve the physical and mental health of young adult survivors of childhood brain tumors.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT05740839

• Training program to improve attention in childhood cancer survivors

  This study is testing if a special video game can help improve attention and thinking skills in kids aged 8-16 who have survived leukemia or brain tumors.

  Recruiting Children's National Research Institute · Washington D.C., District of Columbia · NCT05528939

• Using a diabetes medication to treat pediatric brain and solid tumors

  This study is testing if a diabetes medication can be safely used with regular treatments to help children with hard-to-treat brain and solid tumors.

  Recruiting Phase 1 Washington University School of Medicine · St Louis, Missouri · NCT05521984

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.